These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18649330)

  • 21. Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients.
    Couzi L; Pitard V; Netzer S; Garrigue I; Lafon ME; Moreau JF; Taupin JL; Merville P; Déchanet-Merville J
    J Infect Dis; 2009 Nov; 200(9):1415-24. PubMed ID: 19780672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detailed analysis of IFNg response upon activation permits efficient isolation of cytomegalovirus-specific CD8+ T cells for adoptive immunotherapy.
    Zandvliet ML; Falkenburg JH; Jedema I; Willemze R; Guchelaar HJ; Meij P
    J Immunother; 2009 Jun; 32(5):513-23. PubMed ID: 19609244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants.
    Abate D; Saldan A; Forner G; Tinto D; Bianchin A; Palù G
    J Virol Methods; 2014 Feb; 196():157-62. PubMed ID: 24216234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8+ T-cell maturation following lung transplantation: the differential impact of CMV and acute rejection.
    Westall GP; Brooks AG; Kotsimbos T
    Transpl Immunol; 2007 Nov; 18(2):186-92. PubMed ID: 18005866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
    Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
    Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection.
    Rentenaar RJ; Gamadia LE; van DerHoek N; van Diepen FN; Boom R; Weel JF; Wertheim-van Dillen PM; van Lier RA; ten Berge IJ
    J Clin Invest; 2000 Feb; 105(4):541-8. PubMed ID: 10683384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell response to the cytomegalovirus major capsid protein (UL86) is dominated by helper cells with a large polyfunctional component and diverse epitope recognition.
    Fuhrmann S; Streitz M; Reinke P; Volk HD; Kern F
    J Infect Dis; 2008 May; 197(10):1455-8. PubMed ID: 18444801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CMV-specific central memory T cells reside in bone marrow.
    Letsch A; Knoedler M; Na IK; Kern F; Asemissen AM; Keilholz U; Loesch M; Thiel E; Volk HD; Scheibenbogen C
    Eur J Immunol; 2007 Nov; 37(11):3063-8. PubMed ID: 17960663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV.
    Walker S; Fazou C; Crough T; Holdsworth R; Kiely P; Veale M; Bell S; Gailbraith A; McNeil K; Jones S; Khanna R
    Transpl Infect Dis; 2007 Jun; 9(2):165-70. PubMed ID: 17462006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients.
    Clari MA; Aguilar G; Benet I; Belda J; Giménez E; Bravo D; Carbonell JA; Henao L; Navarro D
    J Med Virol; 2013 Oct; 85(10):1802-10. PubMed ID: 23868746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Girling V; Adler SP
    Vaccine; 2006 Jun; 24(25):5311-9. PubMed ID: 16701925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study.
    Yao J; Bechter C; Wiesneth M; Härter G; Götz M; Germeroth L; Guillaume P; Hasan F; von Harsdorf S; Mertens T; Michel D; Döhner H; Bunjes D; Schmitt M; Schmitt A
    Clin Infect Dis; 2008 May; 46(10):e96-105. PubMed ID: 18419478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations.
    Lautenschlager I; Halme L; Höckerstedt K; Krogerus L; Taskinen E
    Transpl Infect Dis; 2006 Mar; 8(1):21-30. PubMed ID: 16623817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods.
    Schermann CM; Fischer G; Witt V; Kurz M; Potschger U; Fritsch G
    Cytotherapy; 2008; 10(8):834-41. PubMed ID: 19016371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reconstitution of cytomegalovirus specific T cells after pediatric allogeneic stem cell transplantation: results from a pilot study using a multi-allele CMV tetramer group.
    Koehl U; Dirkwinkel E; Koenig M; Erben S; Soerensen J; Bader P; Doerr HW; Preiser W; Weissinger E; Klingebiel T; Martin H; Lehrnbecher T
    Klin Padiatr; 2008; 220(6):348-52. PubMed ID: 18949669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients.
    Lacey SF; La Rosa C; Zhou W; Sharma MC; Martinez J; Krishnan A; Gallez-Hawkins G; Thao L; Longmate J; Spielberger R; Forman SJ; Limaye A; Zaia JA; Diamond DJ
    J Infect Dis; 2006 Nov; 194(10):1410-21. PubMed ID: 17054071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.
    Iancu EM; Corthesy P; Baumgaertner P; Devevre E; Voelter V; Romero P; Speiser DE; Rufer N
    J Immunol; 2009 Jul; 183(1):319-31. PubMed ID: 19542443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Would monitoring CMV immune responses allow improved control of CMV in stem cell transplant patients.
    Ljungman P
    J Clin Virol; 2006 Apr; 35(4):493-5. PubMed ID: 16413823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.
    Lilleri D; Zelini P; Fornara C; Comolli G; Revello MG; Gerna G
    Clin Immunol; 2009 Jun; 131(3):395-403. PubMed ID: 19268633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of cytomegalovirus-specific T helper responses and cytokine production in lung transplant recipients.
    Zeevi A; Spichty K; Banas R; Cai J; Donnenberg VS; Donnenberg AD; Ahmed M; Dauber J; Iacono A; Keenan R; Griffith B
    Intervirology; 1999; 42(5-6):291-300. PubMed ID: 10702709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.